<DOC>
	<DOCNO>NCT01879007</DOCNO>
	<brief_summary>This study seek compare pharmacokinetic characteristic Factive 200mg Intravenous Formulation ( Gemifloxacin 200mg ) Factive 320mg Tablet Formulation ( Gemifloxacin 320mg ) explore possibility clinical use IV formulation .</brief_summary>
	<brief_title>Phase I Trial Pharmacokinetic Characteristics Factive 200mg Intravenous Formulation ( Gemifloxacin 200mg ) With Factive 320mg Tablet Formulation ( Gemifloxacin 320mg )</brief_title>
	<detailed_description />
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Gemifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<criteria>1 . Healthy Korean male 19 45 year age , weigh within 15 % deviation ideal weight ( CRC criterion ) reside Korea ( Appendix 4 ) 2 . Applicants judge eligible subject base health exam ( interview , blood pressure , 12lead ECG , physical exam , blood urine test , screen test ) conduct three week prior administration ( two less clinically significant result ) 3 . Applicants take part whole process clinical study 4 . Applicants sufficiently receive explanation purpose content clinical study , characteristic investigational product , etc. , participate study give write consent participate study voluntarily 1 . Applicants exhibit symptom suspect acute disease prior start study 2 . Clinically significant kidney disease liver disease 3 . Cardiovascular , respiratory , renal , endocrine system , hematology ( hemorrhagic diathresis ) , digestive system ( peptic ulcer ) , central nerve system , psychiatric disorder , malignant tumor ; chronic disease influence absorption , distribution , metabolism , excretion drug 4 . Applicants abnormal diet , influence absorption , distribution , metabolism , excretion drug 5 . Medical history gastrointestinal resection except appendectomy 6 . Applicants test positive hepatitis B antigen , hepatitis C antibody , HIV antibody ; 7 . Clinically significant allergic disease ( exclude mild allergic rhinitis require medication ) 8 . Known history hypersensitivity drug 9 . Known history develop complication epilepsy convulsive disease 10 . Excessive consumption caffeine alcohol heavy smoker 11 . History alcohol drug abuse 12 . Applicants take standard meal provide ASAN Medical Center ( AMC ) 13 . Donation whole apheresis blood prior administration 14 . Participation clinical study subject prior administration 15 . Applicants take prescription drug prior administration OTC ( overthecounter ) drug prior administration medication judge principal investigator influence study safety subject 16 . Applicants highly likely take medication study 17 . Applicants take medication induces inhibit drugmetabolizing enzyme barbiturate consume excessive amount alcohol less 1 month prior administration 18 . Medical history meningitis , encephalitis , brain injury 19 . Difficulty cooperate researcher proceed study</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>